Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional) (345385)

US Dept. of Health & Human Services: National Institutes of Health (NIH)

View website    Save this grant

Next deadline: May 21, 2023 (Letter of inquiry)

Later deadlines: Jun 21, 2023 (Full proposal), Sep 21, 2023 (Letter of inquiry), Oct 21, 2023 (Full proposal), Jan 21, 2024 (Letter of inquiry), Feb 21, 2024 (Full proposal), May 21, 2024 (Letter of inquiry), Jun 21, 2024 (Full proposal), Aug 21, 2024 (Letter of inquiry), Oct 21, 2024 (Full proposal), Jan 21, 2025 (Letter of inquiry), Feb 21, 2025 (Full proposal), May 20, 2025 (Letter of inquiry), Jun 20, 2025 (Full proposal)

Grant amount: Unspecified amount

Fields of work: Neuroscience Mental Health & Psychiatric Diseases Medical Technology & Devices Pharmacology

Applicant type: Government Entity, Nonprofit, For-Profit Business, Indigenous Group

Funding uses: Research

Location of project: Anywhere in the world

Location of residency: Anywhere in the world


NOTE: All applications are due by 5:00 PM local time of applicant organization. 

The overall goal of this initiative is to identify neurophysiological measures potential assays for treatment development research. The funding opportunity announcement (FOA) will support efforts to optimize and evaluate measures of neurophysiological processes that are disrupted within or across mental disorders in both healthy humans and in another species relevant to the therapeutic development pipeline. The initiative will support initial proof of concept studies aimed at identifying measures for potential development as preclinical assays for evaluating potential new drug and device therapies and their targets. Data will also reveal assay measures where the performance between preclinical animal species and humans is dissimilar, thus establishing a firm basis for limiting speculative extrapolations of preclinical animal findings to humans. The ultimate practical goal of this FOA is to improve the efficiency of the therapeutic development process by identifying coherence of measures and inconsistencies between the preclinical screening pipeline and clinical evaluation of new treatment candidates and thereby hasten the development of more effective treatments for mental disorders.

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.

Other Opportunities from Us Dept. Of Health & Human Services: National Institutes Of Health (Nih)

This page was last reviewed January 16, 2023 and last updated January 16, 2023